Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A (Q73273610)
Jump to navigation
Jump to search
scientific article published on 01 March 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A |
scientific article published on 01 March 1997 |
Statements
Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A (English)
H Juhl
F Helmig
K Baltzer
H Kalthoff
D Henne-Bruns
1 March 1997